Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.56 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.53 |
| ▸ | P2RY10 | O00398 | 5/20 | 0.52 |
| ▸ | GPR34 | Q9UPC5 | 2/20 | 0.52 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.51 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.51 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.49 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.49 |
| ▸ | RAD52 | P43351 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7918479 | 1.00 | NAAA (0.56) | NAAANOD1P2RY10GPR34GRIK1 | |
| SCHEMBL7781906 | 1.00 | NAAA (0.56) | NAAANOD1P2RY10GPR34GRIK1 | |
| SCHEMBL7775094 | 1.00 | NAAA (0.56) | NAAANOD1P2RY10GPR34GRIK1 | |
| SCHEMBL1514886 | 0.93 | SLC1A2 (0.49) | NAAANOD1P2RY10GPR34GRIK1 | |
| SCHEMBL476726 | 0.93 | SLC1A2 (0.49) | NAAANOD1P2RY10GPR34GRIK1 | |
| SCHEMBL27532543 | 0.93 | SLC1A2 (0.49) | NAAANOD1P2RY10GPR34GRIK1 | |
| SCHEMBL9442151 | 0.88 | NAAA (0.58) | NAAANOD1P2RY10GPR34HTR2C | |
| SCHEMBL2983597 | 0.88 | NAAA (0.58) | NAAANOD1P2RY10GPR34HTR2C | |
| SCHEMBL2283336 | 0.88 | NAAA (0.58) | NAAANOD1P2RY10GPR34HTR2C | |
| SCHEMBL17231345 | 0.88 | NAAA (0.58) | NAAANOD1P2RY10GPR34HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140288142-A1 | NITRIC OXIDE DONOR COMPOUNDS | NICOX SA (FR) | 2014-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140288142-A1 | NITRIC OXIDE DONOR COMPOUNDS | NOS3, NOS2, NOS1 | NAAA 2391/4885NOD1 1456/4885P2RY10 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.